Literature DB >> 19996586

Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs.

Stefanie Swoboda1, Christoph Lichtenstern, Michael Christoff Ober, Lenka Alexandra Taylor, Dominic Störzinger, André Michel, Angelika Brobeil, Markus Mieth, Stefan Hofer, Hans-Günther Sonntag, Torsten Hoppe-Tichy, Markus Alexander Weigand.   

Abstract

BACKGROUND: Considering the complexity of diagnosis, high costs of therapy and high morbidity and mortality of systemic fungal infections, antifungal therapy of intensive care patients should follow clearly defined guidelines. We outline the impact of a standardised practice of antifungal treatment in an interdisciplinary surgical intensive care unit of a university hospital.
METHODS: Therapy was intended to be optimised by implementation of standardised practice guidelines supported by the clinical pharmacist. Costs for antifungal agents during a period of 18 months before and after implementation of the practice guidelines were compared, respectively.
RESULTS: The intervention was associated with a significant decrease in use of antifungal agents. Analysis of data revealed a reduction in costs by 50%. This could substantially be attributed to the implementation of the practice guidelines.
CONCLUSION: The implementation of standardised practice guidelines for antifungal therapy in intensive care units decreased the use of selected antifungal agents and resulted in substantial reduction in expenditure on antifungal agents. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996586     DOI: 10.1159/000264672

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship.

Authors:  Maricela Valerio; Antonio Vena; Carmen Guadalupe Rodríguez-González; Esther Chamorro de Vega; Miriam Mateos; Maria Sanjurjo; Emilio Bouza; Patricia Muñoz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-04       Impact factor: 3.267

Review 2.  Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.

Authors:  James Gallagher; Suzanne McCarthy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2014-09-14

3.  Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany.

Authors:  Barbara N Gross; Michaela Steib-Bauert; Winfried V Kern; Holger Knoth; Johannes P Borde; Sabine Krebs; Martin J Hug; Ulrich Rothe; Ludwig Maier; Katja de With
Journal:  Infection       Date:  2015-02-17       Impact factor: 3.553

4.  Utilization of fluconazole in an intensive care unit at a university hospital in Brazil.

Authors:  Tânia Pereira Salci; Marina Gimenes; Carlos Aparecido dos Santos; Terezinha Inez Estivalet Svidzinski; Silvana Martins Caparroz-Assef
Journal:  Int J Clin Pharm       Date:  2012-11-28

Review 5.  Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines.

Authors:  Armin Ahmed; Afzal Azim; A K Baronia; Rungmei S K Marak; Mohan Gurjar
Journal:  Indian J Crit Care Med       Date:  2015-06

Review 6.  Healthcare Utilization and Impact of Antifungal Stewardships Within Respiratory Care Settings: A Systematic Literature Review.

Authors:  Salma Aldossary; Anand Shah
Journal:  Mycopathologia       Date:  2021-05-15       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.